GNH USA

Europe — EMA

Migsun (Naproxen Sodium, Sumatriptan Succinate)

GNH USA supplies Migsun (naproxen sodium and sumatriptan succinate), a NSAID/5‑HT1B/1D agonist combination for acute migraine treatment.

Naproxen Sodium, Sumatriptan Succinate

Request sourcing

1
Pack/s

What is Naproxen Sodium, Sumatriptan Succinate?

Naproxen sodium and sumatriptan succinate, the active ingredients in Migsun, are a NSAID/5‑HT1B/1D agonist combination presented as an oral tablet for oral use. It treats acute migraine attacks in adults.

GNH USA supplies Migsun as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Naproxen Sodium, Sumatriptan Succinate used for?

Migsun is a combination drug used in the acute migraine pathway to abort headache episodes. - Acute migraine attack: provides rapid relief of headache and associated symptoms. - Migraine with aura: aborts attacks when taken early in the aura phase. - Migraine recurrence: can be used as a second dose if the first dose does not fully control the episode, under medical supervision.

What are the side effects of Naproxen Sodium, Sumatriptan Succinate?

Migsun may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: transient light‑headedness. - Dry mouth: reduced salivation. - Abdominal pain: discomfort in the stomach area. - Fatigue: feeling unusually tired. - Tingling sensation: paresthesia in extremities.

Serious or Rare Side Effects: - Chest pain: possible cardiac ischemia. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Serotonin syndrome: agitation, hyperthermia, muscle rigidity. - Cardiovascular events: stroke or myocardial infarction. - Severe liver injury: jaundice, elevated enzymes. - Stevens‑Johnson syndrome: serious skin blistering.

What precautions apply to Naproxen Sodium, Sumatriptan Succinate?

Before prescribing Migsun, clinicians should consider several safety factors. - Cardiovascular risk assessment: evaluate patients with coronary artery disease. - Hypertension monitoring: avoid use in uncontrolled high blood pressure. - Serotonergic drug caution: assess risk of serotonin syndrome when combined with other serotonergic agents. - Hypersensitivity screening: do not use in patients allergic to NSAIDs or triptans. - Renal function evaluation: adjust or avoid in severe renal impairment. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

What does Naproxen Sodium, Sumatriptan Succinate interact with?

Migsun can interact with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - MAO inhibitors: increased risk of serotonin syndrome. - Other triptans or ergotamines: risk of severe vasospasm. - Potent CYP3A4 inhibitors: may raise sumatriptan plasma levels. - Anticoagulants or antiplatelet agents: heightened bleeding risk.

Moderate Interactions (Monitor Closely): - NSAIDs with antihypertensives: possible reduction of blood‑pressure control. - SSRIs/SNRIs with sumatriptan: monitor for serotonin syndrome signs. - Naproxen with lithium: monitor lithium serum concentrations.

Frequently asked questions

What is Migsun used for?+
Migsun is prescribed for the acute treatment of migraine attacks in adults. It combines an NSAID with a triptan to relieve headache pain, reduce associated nausea, and stop the progression of migraine symptoms when taken early in an attack.
How does naproxen sodium and sumatriptan work in Migsun?+
Naproxen sodium blocks COX‑1 and COX‑2 enzymes, lowering prostaglandin production and inflammation. Sumatriptan activates 5‑HT1B/1D receptors, causing cranial blood‑vessel constriction and preventing release of neuropeptides that trigger migraine pain, together providing rapid symptom relief.
What is the usual dose of Migsun?+
The specific dose of Migsun is determined by the prescribing clinician based on the patient’s medical history, severity of migraine, and any concomitant medications. Patients should follow the exact dosing instructions provided by their healthcare professional.
Is Migsun safe to use during pregnancy or breastfeeding?+
Migsun is generally not recommended during pregnancy or while breastfeeding unless the potential benefit outweighs the risk. Both naproxen and sumatriptan cross the placenta and may be excreted in breast milk, so clinicians should evaluate safety on a case‑by‑case basis.
How do I order Migsun from GNH USA?+
To request Migsun, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Migsun compare with other migraine treatments?+
Migsun combines an NSAID and a triptan, offering both anti‑inflammatory and vasoconstrictive actions in a single tablet. This can provide faster relief compared with using an NSAID or a triptan alone, and may reduce the need for multiple pills during an attack.
What are the storage requirements for Migsun?+
Migsun should be stored at ambient temperature below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.
How is Migsun administered?+
Migsun is taken orally, usually with a full glass of water. It is recommended to swallow the tablet whole and not to crush or chew it. The medication should be taken as soon as migraine symptoms begin for optimal effectiveness.
What are the most serious risks associated with Migsun?+
Serious risks include cardiovascular events such as chest pain or heart attack, severe allergic reactions like anaphylaxis, and serotonin syndrome when combined with other serotonergic drugs. Patients should seek immediate medical attention if they experience these symptoms.
Who should not use Migsun?+
Migsun should be avoided in individuals with known hypersensitivity to naproxen, other NSAIDs, or sumatriptan; patients with uncontrolled hypertension, recent myocardial infarction, severe coronary artery disease, or those taking MAO inhibitors. A healthcare professional must evaluate suitability before prescribing.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Naproxen Sodium, Sumatriptan Succinate
Route
Oral Use
Manufacturer
Orion Corporation
Origin
EU

Related products

Frimig Duo

Frimig Duo

Naproxen Sodium, Sumatriptan Succinate

Orion Corporation
EU
Frimig Duo

Frimig Duo

Naproxen Sodium, Sumatriptan Succinate

Orion Corporation
EU
Frimig Duo

Frimig Duo

Naproxen Sodium, Sumatriptan Succinate

Orion Corporation
EU
Migsun

Migsun

Naproxen Sodium, Sumatriptan Succinate

Orion Corporation
EU